Malignant Profile Detected by CT Angiographic Information Predicts Poor Prognosis despite Thrombolysis within Three Hours from Symptom Onset
Author(s) -
Volker Puetz,
Imanuel Dzialowski,
Michael D. Hill,
Nikolai Steffenhagen,
Shelagh B. Coutts,
Christine O’Reilly,
Andrew M. Demchuk
Publication year - 2010
Publication title -
cerebrovascular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 104
eISSN - 1421-9786
pISSN - 1015-9770
DOI - 10.1159/000311079
Subject(s) - medicine , thrombolysis , interquartile range , modified rankin scale , stroke (engine) , intracerebral hemorrhage , hematoma , radiology , perfusion scanning , angiography , thrombus , cardiology , perfusion , ischemia , ischemic stroke , subarachnoid hemorrhage , mechanical engineering , myocardial infarction , engineering
A malignant profile of early brain ischemia has been demonstrated in the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) trial. Patients with a malignant profile had a low chance for an independent functional outcome despite thrombolysis within 3-6 h. We sought to determine whether CT angiography (CTA) could identify a malignant imaging profile within 3 h from symptom onset.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom